ADMINISTRATIVE SUPPLEMENTS FOR GENE PROFILING METHODS
Release Date: December 13, 1999
NOTICE: DK-00-001
National Institute of Diabetes and Digestive and Kidney Diseases
The National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK) announces the availability of administrative supplements to NIDDK
grantees to facilitate the development and application of microarray or
other gene profiling technologies. The NIDDK ultimately wishes to
facilitate wide dissemination of these methods and associated resources
to NIDDK grantees. An RFA for gene expression resources to support
projects in areas within the NIDDK’s mission (DK-00-002) has been issued
(NIH Guide, September 23, 1999) and is available at
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-00-002.html. This
administrative supplement program is designed to provide a temporary
mechanism to enable NIDDK investigators to use comprehensive gene
profiling methods.
Investigators currently supported by the following grant mechanisms
funded by NIDDK are eligible to apply: research project (R01), MERIT
award (R37), program project (P01), special centers of excellence
(P50), and research project cooperative agreement (U01). The work
proposed must be within the scope of the research originally
recommended by peer-review. Applicants can request one year of support
for no more than $35,000 in direct costs. Projects must have one year
or more remaining at the time of the anticipated supplement (September
30, 1999).
Each investigator may only submit one application. There is no
restriction on the type of gene profiling technology that the
applicant may select. Examples of research areas appropriate to this
announcement include, but are not limited to (1) determination of
global gene expression patterns and monitoring of changes under
normal and experimental/pathological conditions, (2) identification
of novel expressed sequence tags (ESTs) involved in normal function
and pathogenesis of disease, (3) development of efficient
experimental protocols for using cDNA arrays to study gene expression
patterns in human or animal tissues, including methods to prepare
hybridization probes from small pathology specimens, micro-dissected
tissues, or single cells, (4) enhancement of currently available gene
profiling analysis tools, including data tracking, image analysis,
and bioinformatics tools, (5) development of higher-order analysis
tools and software algorithms to process gene expression data to
predict gene-gene interactions and functional pathways.
NIDDK has set aside up to $1 million in FY 2000 for this one-time
announcement. Requests must be received by March 15, 2000. To apply
for a supplement, send an original letter and 2 copies countersigned
by the grantee institution’s business officer to Dr. Robert A. Star
at the address below.
The letter (5 page limit) must include: 1) an abstract of the
proposed supplemental activity, 2) a detailed description of the
proposed activity, including methodology and resources available, 3)
impact of the requested supplement on ongoing research, 4) expected
outcome, 5) a budget of no more than $35,000 in direct costs for the
one year, carefully justifying methodologies, technologies,
bioinformatics, statistical analytical tools, data-sharing
arrangements, and costs, 6) any pre-existing intellectual property
rights, including options to for-profit research sponsors, associated
with the clones, sequences, and experimental results that may be
generated, and 7) current PI e-mail address. Although these
descriptions should be as concise as possible, sufficient detail must
be provided to allow the NIDDK to judge the merit of the requested
supplement. The current aims of the parent grant should be submitted
as a separate attachment (not included in the 5-page limit).
NIDDK will consider supplement requests from all eligible applicants.
However, because funds are limited, highest priority will be given to
supplement requests that meet the following criteria:
o The proposed experiments are within the scope of the funded project
and will significantly improve its progress.
o The applicant has the resources and expertise necessary to perform
the experiments and agrees to release data in a timely manner.
o The applicant’s plans for quality control and bioinformatics
support are adequate.
o The applicant has carefully documented and justified the requested
budget.
Grantees are encouraged to discuss the request with their NIDDK
program director or the individuals listed below before applying. In
addition, please send an e-mail to [email protected]
indicating the correct e-mail and mailing address of the applicant.
Please place SUBMISSION OF ADMINISTRATIVE SUPPLEMENTS FOR GENE
PROFILING METHODS in the subject field. Acknowledgement of receipt
of the supplement letter will be provided by email. The request will
be evaluated and prioritized by an NIDDK committee of extramural
scientific staff with expertise in the scientific area. No written
critique will be provided. Award decisions will be based upon
000000scientific merit, availability of funds, and programmatic
priorities, including program relevance of the hypothesis-driven
scientific project that will be aided by the advanced technology.
Funds will be awarded by September 30, 2000.
Answers to Frequently Asked Questions (FAQ) will be available at
http://www.niddk.nih.gov under FAQ. Direct inquiries regarding
programmatic issues to:
Robert A. Star, M.D.
Division of Kidney, Urologic, and Hematologic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
45 Center Drive MSC 6600
Bethesda, MD 20892-6600
Phone: (301) 594-7715
FAX: (301) 480-3510
E-mail: [email protected]
Philip F. Smith, Ph.D.
Division of Diabetes, Endocrinology, and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
45 Center Drive MSC 6600
Bethesda MD 20892-6600
Phone: (301) 594-8816
FAX: (301) 480-3503
E-mail: [email protected]
Jose Serrano, M.D., Ph.D.
Division of Digestive Diseases and Nutrition
National Institute of Diabetes and Digestive and Kidney Diseases
45 Center Drive MSC 6600
Bethesda MD 20892-6600
Phone: (301) 594-8871
FAX: (301) 480-8300
E-mail: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
|
NIH... Turning Discovery Into Health®
|